Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

Rates of Positive BCCs in Re-excisions

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01403480

Enrollment

600

Registered

2011-07-27

Start date

2008-01-31

Completion date

2011-02-28

Last updated

2011-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma

Keywords

Basal Cell Carcinoma

Brief summary

Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All patients that underwent an incomplete BCC excision during the years 2008-2010.

Exclusion criteria

Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.

Outcome results